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Abstract
Background Cambodia has one of the highest rates of
overall medical injection usage worldwide. Therapeutic
injections, which are often unnecessary, contribute to the
spread of blood-borne diseases.
Objective This study describes injection practices and
associated household expenditures in rural northwest
Cambodia.
Methods We assessed care-seeking patterns of surveyed
adult family members who sought healthcare in the pre-
vious 30 days, including location of care, medical injection
use, and out-of-pocket household expenditures for treat-
ment. A regression model was used to explore the impact
of injection use on out-of-pocket household expenditures.
Results Among 480 households sampled, 298 included
members who had been sick within the previous 30 days; a
total of 342 episodes of care had been sought. Private
providers accounted for over 66% (n = 226) of all epi-
sodes of care, with public and informal providers
accounting for 20% (n = 69) and 14% (n = 47), respec-
tively. Injections were administered in over 120 (35%)
episodes of care, with 81% of injections administered by
private providers. Patients who received injections incurred
total out-of-pocket household expenditures that were, on
average, 126,590 Cambodian Riel (KHR) (US$31.65)
higher than those who did not receive injections (p\0.01),
equivalent to nearly half of the country’s total annual
health expenditure per capita. Receiving injections and
perceived severity of illness were significantly associated
with higher out-of-pocket household expenditures.
Conclusion This study found high levels of medical injection
use, particularly among private healthcare providers, which
was significantly associated with high healthcare expendi-
tures. Reducing the number of medical injections would not
only reduce disease transmission risk but also contribute to
reduced healthcare costs and greater financial protection.
Key Points for Decision Makers
We observed high levels of medical injection use,
particularly among private healthcare providers in
Cambodia.
Injections increased average out-of-pocket
expenditures per treatment significantly—the
increase was equivalent to nearly half of the total
annual health expenditure per capita.
Reducing the number of medical injections would
lower the risk of disease transmission and prevent
households from incurring large health expenditures.
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1 Introduction
The World Health Organization (WHO) estimates that up
to 90% of global injection prescriptions are unnecessary
and could be replaced by oral formulations [1, 2]. Oral
formulations are often safer for patients and healthcare
workers and more cost-effective than injectables [3, 4]. The
overuse of medical injections is associated with unsafe
injection practices and has been linked with transmission of
blood-borne infectious diseases [5–7]. Globally, it is esti-
mated that unsafe injections transmit 21 million hepatitis B
infections, 2 million hepatitis C infections and 260,000
HIV infections each year [8]. High use of injections is also
associated with high rates of needle stick injuries among
healthcare workers [4]. Safe and appropriate use of injec-
tions contributes to WHO’s global patient safety challenge
‘Medication Without Harm,’ which aims to reduce severe
avoidable medication-related harm by 50% globally over
the next 5 years [9].
Cambodia has one of the highest rates of overall medical
injection usage worldwide [10], where more than one in
three individuals reported receiving a medical injection in
the previous 12 months [11]. The overuse of injections and
utilization of unsterile equipment has caused multiple out-
breaks of HIV in rural Cambodian communities. For
example, repeated use of HIV-infected syringes in Roka
Commune in 2014 resulted in 242 confirmed new cases of
HIV [12, 13]. Moreover, 65% of injections are reported to be
administered in patients’ homes, which are not equipped for
safe injections or to handle injection-related complications
[11]. Overuse of injections is likely driven by a perception
that injections have greater potency than oral formulations
as well as providers’ prescribing practices [14].
In Cambodia, healthcare expenditures are the second
greatest household expense, and 74% of healthcare
expenditures are paid out-of-pocket [15]. Health expendi-
tures cause medical impoverishment among 4.1% of
Cambodian families each month [16]. To reduce out-of-
pocket health expenditures, Cambodia has introduced
health equity funds (HEF), which provide free healthcare at
public health facilities for the poorest individuals, covering
about one-quarter of the population [15, 17, 18]. Commu-
nity-based health insurance (CBHI) schemes have also
been introduced, but they cover less than 1% of the pop-
ulation, while other private health insurance schemes cover
an even smaller proportion of the population [15, 19, 20].
Moreover, neither HEF nor CBHI cover services provided
by private healthcare providers, where more than two-
thirds of care is sought and where most injections are
administered [10, 21]. Hence, even with insurance and
supply-side subsidies, patients are still at risk of incurring
large injection-related health expenditures.
We conducted a household survey in northwest Cam-
bodia to gain an understanding of the utilization of and
financial burden from medical injections. We describe
healthcare injection practices across public, private and
informal providers, including frequency of injections and
associated out-of-pocket health expenditures by house-
holds. Findings from the study can inform the design of
interventions and policies to reduce the use of injections,
reduce catastrophic health expenditures and highlight the
financial burden that injections impose on Cambodian
households.
2 Methods
We conducted a household survey in two rural health
operational districts (ODs) in Cambodia: Thmar Pouk OD
in Banteay Meanchey province and Samrong OD in Oddar
Meanchey province. Eight villages in each OD were ran-
domly selected based on the size of the village population,
the health centre coverage (one village per health centre)
and the distance between the village and the nearest health
centre. We surveyed 480 households using a standard
cluster sampling methodology, interviewing 30 households
in each of the 16 villages. Participants were heads of
households or their spouses aged[18 years who were not
medical practitioners. Only households that reported hav-
ing a sick member in the previous 30 days were included in
this analysis.
Each healthcare visit was counted as an episode of care,
and up to three healthcare visits were recorded per house-
hold. From each household, we collected basic demo-
graphic data about the respondent, as well as information
about the family member’s illness, healthcare utilization
and self-reported total out-of-pocket household expendi-
tures for each episode of care. The health providers/facili-
ties where sick household members received care were
categorized as either public, private or informal. Public
facilities and/or providers included hospitals in Phnom
Penh, provincial hospitals, Thmar Pouk district hospital or
health centres. Private facilities and/or providers included
private hospitals, private clinics, home/office of trained
health workers, visits by trained health workers, and phar-
macies. The remaining facilities and/or providers were
classified as informal: shops/markets selling drugs, Kru
Khmer (traditional healers), monks/religious leaders, tra-
ditional birth attendants or other informal providers.
Household expenditures included spending on provider
and facility charges, medications, travel to seek healthcare,
meals and other incidental costs. We asked about health
insurance status, as this area is covered by a CBHI
scheme operated by a local non-governmental organization
called Cambodian Association for Assistance to Families
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and Widows (CAAFW). This voluntary insurance coverage
is available for enrolled families and can be used only at
public providers. Coverage under the scheme includes most
services at health centres and referral hospitals in the area.
Data were analysed by episode of care using the Stata
software (StataCorp. 2015 Stata Statistical Software:
Release 14. College Station, TX, USA). We used Chi
squared and t tests to examine whether there were any dif-
ferences between respondents’ demographic characteristics
and episode of care for those who received injections and
those who did not. We summarized the total out-of-pocket
household expenditures per episode of illness. Cambodian
Riel (KHR) were converted to US dollars at KHR4000 per
US$1 [22]. Some respondents were unable to recall their
households’ expenditures, so we analyzed the subset with
data on household expenditures. We compared household
expenditures across four categories of treatment: no treat-
ment, received oral medications only, received injections
only and received both injections and oral medications.
We used a linear regression model to assess the impact
of receiving injections on out-of-pocket household expen-
diture per episode of illness while controlling for respon-
dent characteristics. Specifically, our analysis controlled
for respondent age, health provider/facility, perceived
severity of illness and receiving oral medications, which
were statistically significantly different between respon-
dents who received injections and those who did not.
3 Results
We recruited 480 households, 312 of which had members
who had been sick in the 30 days preceding the survey; 298
households (95%) had sought care in the previous 30 days.
Among households that sought care, 342 episodes of care
were received from health providers. Of the episodes of care,
226 (66%) were at a private provider, 69 (20%) at a public
provider and 47 (14%) at an informal provider. While most
care was sought during one visit, 44 (13%) were repeat visits
for the same illness. Figure 1 summarizes the flow of
households recruited and their care-seeking patterns.
Injections were administered in 35% (n = 120) of all
treatments sought. Household members were more likely to
have received injections if they perceived their illness as
severe (55%, n = 46; p\0.001) and if they received care
at a private provider (81%, n = 98; p\0.001). While those
who received injections received fewer oral medications
(p\0.001), 86% (n = 103) received both injections and
oral medications. Respondents in households that received
injections were older than respondents in households that
did not (43.5 vs. 40.1 years, respectively; p = 0.02).
Table 1 summarizes the characteristics of respondents and
compares those who received injections with those who did
not, by episode of care. Socioeconomic status and household
health insurance status were not significantly different between
households that received injections and those that did not.
Sample Households
N = 480
No Illness
N = 168
Illness
N = 312
Did not seek care
N = 14
Sought care
N = 298
Total episodes of care
N = 342
Informal Provider
N = 47
Private Provider
N = 226
Public Provider 
N = 69
Visit 1
N = 56
Visit 2
N = 11
Visit 3
N = 2
Visit 1
N = 199
Visit 2
N = 21
Visit 3
N = 6
Visit 1
N = 43
Visit 2
N = 3
Visit 3
N = 1
Fig. 1 Care-seeking patterns of surveyed households
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Total out-of-pocket household expenditures per episode
of care ranged widely by type of treatment received
(Table 2). Households whose members received both oral
medication and injections had the highest average out-of-
pocket household expenditures (mean KHR208,726,
US$52.18). Households whose members only received
injections had the second highest total out-of-pocket
household expenditure (mean KHR102,666, US$25.67).
Those who received only oral medication incurred the
lowest total out-of-pocket household expenditures
(KHR34,938, US$8.41). In only four episodes of care,
neither oral medication nor injections were given.
Findings from our linear regression model examining
the impact of receiving injections on total out-of-pocket
household expenditure are summarized in Table 3.
Receiving injections was significantly associated with
KHR126,590 (US$31.65) more total out-of-pocket house-
hold expenditure per episode of care, controlling for
household respondent’s age, receiving oral medication,
health provider type and severity of illness.
4 Discussion
Our study found that sick household members received
injections as part of their treatment in more than one-third
of all care sought. Private providers administered the
majority (81%) of these injections. Most patients (86%)
who received injections also received oral medications.
This suggests that injections are not being administered as
substitutes for oral formulations but are rather being added
to the treatment mix.
Table 1 Characteristics of survey respondents by injection use
Respondent characteristics Received injections (n = 120) Did not receive injections (n = 222) p values
Age, years 43.54± 13.44 40.09± 12.66 0.019*
Sex
Male 10.83 8.56 0.491
Female 89.17 91.44
Marital status
Single 2.50 2.25 0.817
Married 79.17 81.98
Widowed/divorced/separated 18.33 15.77
Years of schooling 2.75± 3.05 2.38± 2.76 0.255
Current health status
Excellent 0.83 0.00 0.430
Very good 4.17 5.41
Good 23.33 19.37
Fair 53.33 51.35
Poor 18.33 23.87
Perceived illness severity
Severe 55.00 19.82 \0.001*
Not severe 45.00 80.18
Received oral medication 86.67 98.20 \0.001*
Health facility/provider type
Public 15.00 22.97 \0.001*
Private 81.67 57.66
Informal 3.33 19.37
Households with health insurance 15.00 22.52 0.096
Socioeconomic status
Low 15.83 23.87 0.199
Low-medium 17.50 22.97
Medium 21.67 16.67
Medium–high 23.33 18.47
High 21.67 18.02
Data are presented as N or mean± standard deviation unless otherwise indicated
*Significant at p\0.05
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Receiving injections was significantly associated with
higher total out-of-pocket household expenditure per epi-
sode of care, at an average of US$31.65 (95% confidence
interval [CI] 19.41–43.88) more. In comparison, Cambo-
dia’s current total annual health expenditure per capita is
US$70, including government expenditures [23]. Cambo-
dia’s current out-of-pocket expenditure per capita is US$41
per year [23]. These results are significant, as Cambodia
seeks to improve the quality of healthcare and reduce
healthcare-driven poverty. While this study cannot deter-
mine what proportion of the injections given were appro-
priate, the high prevalence of injections suggests that some
are likely to be unnecessary and/or inappropriate. The
higher costs incurred by patients for injections could
potentially be prevented by reducing injection use and
improving the standard of care.
The proportion of households in our study that sought
care (95%) and the types of health provider from which
they sought the care (mostly private) was consistent with
findings from the Cambodia demographic health survey
(DHS) conducted in 2014 [11]. The prevalence of injection
use (35%) found in our study was higher than the 2014
DHS estimate for Oddar Meanchey province (24%) and
lower than the estimate for Banteay Meanchey province
(39%) [11]. The prevalence of injection use in the study
was also similar to that found among patients using
injections for malaria treatment in northeast Cambodia
[24]. Some study design differences may explain the
recorded prevalence. While the DHS survey recorded
injections received within the previous 12 months among
people aged 15–49 years, our study recorded injections
received within the previous 30 days regardless of recipi-
ent’s age. Furthermore, the DHS survey asked respondents
directly about any injections received, whereas our study
asked household representatives, who may not have
received the injections themselves.
The highest average total out-of-pocket household
expenditures in our study (KHR208,726, US$50.26) were
incurred for episodes of care in which patients received
both injections and oral medications. In contrast, average
total health treatment costs in the 2014 DHS survey were
US$57.08 in Banteay Meanchey and US$55.33 in Oddar
Meanchey. The healthcare expenditure estimates reported
in the DHS survey were across all ages and thus can be
directly compared to those in our sample.
High medical injection use in developing countries such
as Cambodia is spurred by the perception that injections are
a more potent and effective form of treatment than oral
pills [25], leading to high demand from patients
[24, 26–28]. High use of medical injections in Cambodia
Table 2 Household out-of-pocket expenditures per episode of care by treatment
Received injections
only
Received injections and oral
medication
Received oral medication
only
Received neither injection or oral
medicationb
N 15 101 215 4
Mean± SD, KHR 102,666± 120,352 208,726± 344,625 34,938± 62,064 167,500± 173,853
Median, KHR 75,000 100,000 12,500 125,000
Mean± SD, US$a 25.67± 30.09 52.18± 86.16 8.73± 15.52 41.88± 43.46
Median, US$ 18.75 25.00 3.13 31.25
Reports on the subset of episodes of care with household expenditure data (N = 335)
KHR Cambodian Riel, SD standard deviation
aConversion at KHR4000 = US$1
bNo injections or oral medications were given in 4 episodes of care, where costs were incurred for other types of medical procedures
Table 3 Summary of
generalized linear model of
predictors of total visit costs
Variable Coefficient Standard error p value
Received injection(s) 126,590.20 24,873.59 \0.001*
Respondent’s age 358.45 838.91 0.669
Health facility/provider type - 5433.27 18,713.05 0.772
Perceived illness severity 95,373.28 24,957.89 \0.001*
Received oral medication 36,181.88 48,107.24 0.453
Adjusted R2 0.1545
F 13.20
*Significant at p\0.05
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has been documented for malaria treatment, particularly in
the private sector, with 32% of households surveyed
receiving injections for their last malaria treatment [24].
Among those receiving injections, single-dosage injections
were popular and sought from providers, likely contribut-
ing to increased drug resistance [24]. Perverse financial
incentives are an important factor contributing to overuse
of injections, with higher revenue from injections and other
expensive treatments leading to irrational prescribing
behaviours [29, 30]. There is evidence that promotional
practices and incentives from pharmaceutical companies
also drive irrational drug use, including over-prescription
of injections [31–33].
Reducing the overuse of injections in Cambodia will
require a multisector approach, given the multi-faceted
causes of injection overuse. Interventions to reduce the use
of medical injections will likely need to target behaviour
change among both medical providers and patients, similar
to those proven successful and cost-effective in other set-
tings [34–36]. Nevertheless, even with educational inter-
ventions, it is difficult to change the behaviour of all actors
involved in injection use. Thus, at least in the short term, it
may be imperative to adopt strategies that work to make
current injections safer, while working to reduce injection
use in the long term. The WHO, under the auspices of the
Safe Injection Global Network (SIGN), has established the
cost-effectiveness of this two-pronged intervention
approach [37].
A number of study limitations must be noted. The study
did not obtain clinical diagnoses of illness for which
household members sought care, thus we were unable to
definitively ascertain the appropriateness of injections
received. Our estimates of out-of-pocket household
expenditure were obtained through self-reporting and are
thus subject to recall bias. Furthermore, patient household
expenditures are only part of a broader range of health
system costs associated with injection overuse. Costs borne
by government through supply-side financing of injections,
costs of infections caused by unnecessary injections and
economic costs incurred by healthcare workers through
needle stick injuries also need consideration. Future studies
should consider a broader perspective of costs associated
with injections and use administrative data and other health
records, where available, to improve the accuracy of esti-
mates. Finally, the regression assumed each episode of care
was independent, but this assumption may not hold in
instances where the same household member received care
in multiple visits.
This study adds to the literature on the overuse of
therapeutic injections in Cambodia. Furthermore, the study
demonstrates the high economic burden, from the house-
hold perspective, associated with receiving injections.
Together with evidence on public health harm, the findings
on the economic burden on patients in this study highlight
the need for interventions to reduce the use of injections in
health facilities, especially among private providers. In
addition to reducing the risk of injection-transmitted
infections and injection-related sequelae, such interven-
tions may have important cost-saving implications for
patients and the health system overall, which is a key
outcome in the push for universal health coverage in
Cambodia [38].
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